12 Month Results from SELUTION4ISR & SELUTION DeNovo Clinical Trials

 

 

Agenda:

  • Evolution of PCI - Alexandre Abizaid, MD
  • What’s different about Selution? - Aloke Finn, MD
  • SELUTION DeNovo Study Discussion - Christian Spaulding, MD, and Simon Eccleshall, MD
  • SELUTION4ISR Study Discussion - Donald Cutlip, MD
  • Role of DEB in Clinical Practice: Panel Discussion - Azeem Latib, MD, and Alexandre Abizaid, MD

SELUTION SLRTM Drug-Eluting Balloon is approved in the United States for investigational use only. Not available for commercial use.

 

FACULTY

Alexandre Abizaid, MD  

Alexandre Abizaid, MD
Instituto do Coração
São Paulo, Brazil

 Don Cutlip, MD  

Don Cutlip, MD
Beth Israel Deaconess Medical Center
Boston, MA
Simon Eccleshall, MD  

Simon Eccleshall, MD
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norwich, United Kingdom

 Aloke Finn, MD  

Aloke Finn, MD
CVPath Institute Inc.
Gaithersburg, MD
Azeem Latib, MD  

Azeem Latib, MD
Montefiore Health System
Bronx, NY

 Christian Spaulding, MD  

Christian Spaulding, MD
European Hospital Georges Pompidou
Paris, France

 

This program was supported by:

 

 

Cordis